• Conventional medicine and homeopathy work well together. • Quality of life improves with additive homeopathy in patients with non-small cell lung cancer (NSCLC). • Survival improves with additive homeopathy in patients with NSCLC.
The symptoms of patients undergoing homeopathic treatment were shown to improve substantially and conventional medication dosage could be substantially reduced. While the real-life effect assessed indicates that there is a potential for enhancing therapeutic measures and reducing healthcare cost, it does not allow to draw conclusions as to the efficacy of homeopathic treatment per se.
In the Additional Details of Endpoints or Study Design section of this report, it was reported that "Eight of the randomized patients had to be excluded because of sensitizing EGFR mutations or ALK translocations reported immediately after randomization (four in the homeopathy group, four in the control group)." In the parenthetical note, "control group" should have been "placebo group". This error does not affect the results of this study, but in the interest of clarity, the online version of this article has been corrected.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.